Since we observed that the targeting of HH-GLI was able to indirectly also target the NOTCH pathway, we wondered if the combination of 5-FU and GANT61 could affect cell motility, a key feature of EMT and therefore of CRC aggressiveness. Here, GLI1 is linked to colorectal carcinoma.